- Sections
- C - Chimiemétallurgie
- C12N - Micro-organismes ou enzymescompositions les contenantculture ou conservation de micro-organismestechniques de mutation ou de génétiquemilieux de culture
- C12N 15/08 - Cellules résultant d'une fusion inter-espèces
Détention brevets de la classe C12N 15/08
Brevets de cette classe: 30
Historique des publications depuis 10 ans
|
0
|
0
|
2
|
2
|
1
|
0
|
1
|
1
|
1
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| President and Fellows of Harvard College | 6047 |
2 |
| Adverum Biotechnologies, Inc. | 97 |
2 |
| Cellscript, LLC. | 19 |
2 |
| Cytomatrix Pty Ltd | 6 |
2 |
| Lankenau Institute for Medical Research | 96 |
2 |
| University of Washington | 2386 |
2 |
| Novartis AG | 10595 |
1 |
| Massachusetts Institute of Technology | 10161 |
1 |
| Life Technologies Corporation | 3351 |
1 |
| Novozymes, Inc. | 287 |
1 |
| Kyoto University | 2856 |
1 |
| National University Corporation Okayama University | 458 |
1 |
| Ngee Ann Polytechnic | 49 |
1 |
| The Ohio State University Research Foundation | 513 |
1 |
| OncoSec Medical Incorporated | 23 |
1 |
| Sakata Seed Corporation | 298 |
1 |
| Sowakai Medical Foundation | 13 |
1 |
| The University of Tokyo | 4252 |
1 |
| Zhejiang University | 3272 |
1 |
| The Board of Regents of the University of Texas System | 2236 |
1 |
| Autres propriétaires | 4 |